Trilogy Capital’s Freeport-McMoran FCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-335,000
Closed -$283K 395
2025
Q3
$283K Buy
335,000
+162,500
+94% +$7.05M 0.01% 319
2025
Q2
$271K Buy
172,500
+133,500
+342% +$5.07M 0.01% 306
2025
Q1
$73.9K Buy
+39,000
New +$1.49M ﹤0.01% 331
2024
Q3
Sell
-119,500
Closed -$99.2K 331
2024
Q2
$99.2K Buy
+119,500
New +$6.02M 0.01% 312

Other funds holding FCX

Trilogy Capital's FCX Position: Q2 2026 in Review

Trilogy Capital increased its Freeport-McMoran (FCX) stake by 0.23% in Q2 2026, buying an estimated $26.7K and bringing the position to 181,613 shares worth $11.4M. The position accounts for 0.44% of the portfolio, ranked #45.

Trilogy Capital first reported a position in FCX in Q1 2018 and has held it in 13 quarters since. The position peaked at $11.7M in Q4 2025. 536 funds tracked by Wall St. Rank hold FCX as of Q2 2026.

  • Trilogy Capital held 181,613 shares of Freeport-McMoran worth $11.4M as of Q2 2026.
  • Trilogy Capital bought 416 Freeport-McMoran shares in Q2 2026, an estimated $26.7K.
  • Freeport-McMoran made up 0.44% of Trilogy Capital's portfolio in Q2 2026, its #45 holding.
  • Trilogy Capital first reported a position in Freeport-McMoran in Q1 2018 and has held it in 13 quarters since.
  • Trilogy Capital's Freeport-McMoran position peaked at $11.7M in Q4 2025.
  • 536 funds tracked by Wall St. Rank held Freeport-McMoran as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.